Camena Bioscience

About Camena Bioscience

Camena Bioscience is a company focused on rewriting DNA synthesis technology. Their mission is to provide innovative solutions for producing synthetic DNA of any length and complexity at scale, supporting biotechnology advancements, accelerating discovery pipelines, and promoting sustainability in healthcare through green synthesis technology.

Products & Services

gSynth Platform:A TdT-free enzymatic-based DNA synthesis technology for high-throughput production of synthetic genes of any sequence, length, or complexity. It enables rapid synthesis of kilobases of DNA in a day, supports applications like mRNA vaccines, cell and gene therapies, and CRISPR screening, and offers sequence security through in-house synthesis.

Specialties

DNA Synthesis Technology Enzymatic DNA Synthesis Synthetic Gene Production mRNA Vaccine Development Cell and Gene Therapies CRISPR Screening Sustainable Healthcare Solutions

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series A T: - FT: Series A	A: 10000000 MR: - FA: $10m FAN: 10000000	D: 2023-07-03 FD: 2023-07-03	1 investors

Series A Latest

2023-07-03

$10.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Steve Harvey

CEO & Co-founder

LinkedIn (Pro only)

D

Derek Stemple

CSO & Co-founder

LinkedIn (Pro only)

A

Aditya

Board Chair

LinkedIn (Pro only)

P

Philip

Board member

J

James Richardson

RVP, R&D

J

James Allen

Principal Software Engineer

View 28 more team members with Pro

Unlock Full Team Directory

Recent News